Literature DB >> 25569631

Multi-synergetic ZnO platform for high performance cancer therapy.

Nirmalya Tripathy1, Rafiq Ahmad, Hyun Ah Ko, Gilson Khang, Yoon-Bong Hahn.   

Abstract

ZnO platforms were evaluated for designing a high-performance anticancer drug (daunorubicin) carrier. Hollow structured ZnO, compared with nanorods, acts as a multi-purpose entity by serving as smart carriers and exhibiting synergetic photodynamic cytotoxic effects, which are ascribed to their high-specific surface area, hollow interior, pH-responsiveness and inherent photodynamism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25569631     DOI: 10.1039/c4cc10037a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

Review 1.  Metal oxide modified ZnO nanomaterials for biosensor applications.

Authors:  Nirmalya Tripathy; Deok-Ho Kim
Journal:  Nano Converg       Date:  2018-10-03

2.  Two Hybrid Au-ZnO Heterostructures with Different Hierarchical Structures: Towards Highly Efficient Photocatalysts.

Authors:  Shuo Yang; Lijing Wang; Yongsheng Yan; Lili Yang; Xin Li; Ziyang Lu; Hongju Zhai; Donglai Han; Pengwei Huo
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.